Metformin prevents endotoxin-induced liver injury after partial hepatectomy

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 3, 2006, Pages 1053-1061

  Bergheim, Ina ^a   Luyendyk, James P ^b   Steele, Chad ^c   Russell, Gilandra K ^a   Guo, Luping ^a   Roth, Robert A ^b   Arteel, Gavin E ^a  

^a University of Louisville School of Medicine   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME BLOOD LEVEL; FIBRIN DEPOSITION; HEPATITIS; HISTOLOGY; LIVER INJURY; LIVER PROTECTION; LIVER RESECTION; MALE; NEUTROPHIL COUNT; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS; THROMBOSIS;

ANIMALS; CARBOHYDRATE METABOLISM; CYTOKINES; HEPATECTOMY; HYPOGLYCEMIC AGENTS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; MALE; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; URINARY PLASMINOGEN ACTIVATOR;

EID: 33644768265     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.092122     Document Type: Article

References (40)

1. Anfosso F, Chomiki N, Alessi MC, Vague P, and Juhan-Vague I (1993) Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. J Clin Investig 91:2185-2193.
2. Arii S, Shibagaki M, Takahashi S, Taki Y, Yokoo N, Jikko A, Tanaka J, Kamiyama Y, Takasan H, Ozawa K, et al. (1985) Changes in the reticuloendothelial phagocytic function after partial hepatectomy. J Lab Clin Med 105:668-672.
3. Bastard JP, Pieroni L, and Hainque B (2000) Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev 16:192-201.
4. Bezerra JA, Currier AR, Melin-Aldana H, Sabla G, Bugge TH, Kombrinck KW, and Degen JL (2001) Plasminogen activators direct reorganization of the liver lobule after acute injury. Am J Pathol 158:921-929.
5. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, and Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature (Lond) 368:419-424.
6. Carter EA (1998) Insulin resistance in burns and trauma. Nutr Rev 56:S170-S176.
7. Chaudry IH, Sayeed MM, and Baue AE (1974) Insulin resistance in experimental shock. Arch Surg 109:412-415.
8. Cybulsky MI, Chan MK, and Movat HZ (1988) Acute inflammation and microthrombosis induced by endotoxin, interleukin-1 and tumor necrosis factor and their implication in Gram-negative infection. Lab Investig 58:365-378.
9. D'Amico D and Cillo U (1999) Impact of severe infections on the outcome of major liver surgery: a pathophysiologic and clinical analysis. J Chemother 11:513-517.
10. Fearns C and Loskutoff DJ (1997) Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alpha. Am J Pathol 150:579-590.
11. Grant PJ (2003) Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab 29:6S44-6S52.
12. Healy AM and Gelehrter TD (1994) Induction of plasminogen-activator inhibitor-1 in Hepg2 human hepatoma cells by mediators of the acute-phase response. J Biol Chem 269:19095-19100.
13. He G, Pedersen SB, Bruun JM, Lihn AS, and Richelsen B (2003) Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro. Horm Metab Res 35:18-23.
14. Jagneaux T, Taylor DE, and Kantrow SP (2004) Coagulation in sepsis. Am J Med Sci 328:196-204.
15. Jeschke MG, Einspanier R, Klein D, and Jauch KW (2002) Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8:443-450.
16. Jeschke MG, Klein D, Bolder U, and Einspanier R (2004) Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145:4084-4093.
17. Kruithof EK (1988) Plasminogen activator inhibitors - a review. Enzyme 40:113-121.
18. Lagoa CE, Vodovotz Y, Stolz DB, Lhuillier F, McCloskey C, Gallo D, Yang R, Ustinova E, Fink MP, Billiar TR, and Mars WM (2005) The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 42:390-399.
19. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, and Diehl AM (2000) Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6:998-1003.
20. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, and Melchionda N (2001) Metformin in non-alcoholic steatohepatitis. Lancet 358:893-894.
21. Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, and Zakynthinos SG (2001) Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 27:1853-1859.
22. Ma Y, Toth B, Keeton AB, Holland LT, Chaudry IH, and Messina JL (2004) Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 145:5168-5176.
23. Mesters RM, Florke N, Ostermann H, and Kienast J (1996) Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost 75:902-907.
24. Mochida S, Ogata I, Hirata K, Ohta Y, Yamada S, and Fujiwara K (1990) Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 99:771-777.
25. Morrison DC and Ryan JL (1987) Endotoxins and disease mechanisms. Annu Rev Med 38:417-432.
26. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, and Rossetti L (2004) Role of resistin in diet-induced hepatic insulin resistance. J Clin Investig 114:232-239.
27. Nair S, Diehl AM, Wiseman M, Farr GH Jr, and Perrillo RP (2004) Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 20:23-28.
28. Pandey M, Loskutoff DJ, and Samad F (2005) Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes. FASEB J 19:1317-1319.
29. Postic C, Dentin R, and Girard J (2004) Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30:398-408.
30. Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, and Kruithof EK (1989) Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 61:459-462.
31. Quax PH, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJ, Kuiper J, and Emeis JJ (1990) Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 265:15560-15563.
32. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, and Olefsky JM (2004) Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Investig 114:224-231.
33. Sawdey MS and Loskutoff DJ (1991) Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha and transforming growth factor-beta. J Clin Investig 88:1346-1353.
34. Seki T and Gelehrter TD (1996) Interleukin-1 induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression in the mouse hepatocyte line, AML 12. J Cell Physiol 168:648-656.
35. Standeven KF, Ariens RA, Whitaker P, Ashcroft AE, Weisel JW, and Grant PJ (2002) The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization and fibrin clot formation. Diabetes 51:189-197.
36. Strassheim D, Park JS, and Abraham E (2002) Sepsis: current concepts in intracellular signaling. Int J Biochem Cell Biol 34:1527-1533.
37. Tsuchiya H, Kaibori M, Yanagida H, Yokoigawa N, Kwon AH, Okumura T, and Kamiyama Y (2004) Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol 40:94-101.
38. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, and Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367.
39. Waynforth HB and Flecknell PA (1992) Experimental and Surgical Technique in the Rat. Academic Press, San Diego, CA.
40. Yamamoto K and Loskutoff DJ (1996) Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Investig 97:2440-2451.